nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MMAA—brainstem—malignant glioma	0.0133	0.0559	CbGeAlD
Hydroxocobalamin—CASP9—telencephalon—malignant glioma	0.0103	0.0435	CbGeAlD
Hydroxocobalamin—MMACHC—central nervous system—malignant glioma	0.0102	0.043	CbGeAlD
Hydroxocobalamin—MMAB—medulla oblongata—malignant glioma	0.00868	0.0365	CbGeAlD
Hydroxocobalamin—AMN—cerebellum—malignant glioma	0.00822	0.0346	CbGeAlD
Hydroxocobalamin—MMACHC—brain—malignant glioma	0.00811	0.0341	CbGeAlD
Hydroxocobalamin—MMAB—midbrain—malignant glioma	0.00793	0.0334	CbGeAlD
Hydroxocobalamin—MUT—telencephalon—malignant glioma	0.00792	0.0334	CbGeAlD
Hydroxocobalamin—MTRR—telencephalon—malignant glioma	0.00712	0.03	CbGeAlD
Hydroxocobalamin—MMAA—central nervous system—malignant glioma	0.0067	0.0282	CbGeAlD
Hydroxocobalamin—AMN—brain—malignant glioma	0.00668	0.0281	CbGeAlD
Hydroxocobalamin—MMAA—cerebellum—malignant glioma	0.00654	0.0276	CbGeAlD
Hydroxocobalamin—MMAB—central nervous system—malignant glioma	0.00628	0.0264	CbGeAlD
Hydroxocobalamin—MUT—medulla oblongata—malignant glioma	0.00623	0.0262	CbGeAlD
Hydroxocobalamin—MTR—telencephalon—malignant glioma	0.00621	0.0261	CbGeAlD
Hydroxocobalamin—MMAB—cerebellum—malignant glioma	0.00614	0.0258	CbGeAlD
Hydroxocobalamin—CASP9—central nervous system—malignant glioma	0.00587	0.0247	CbGeAlD
Hydroxocobalamin—CASP9—cerebellum—malignant glioma	0.00573	0.0241	CbGeAlD
Hydroxocobalamin—TCN2—central nervous system—malignant glioma	0.00573	0.0241	CbGeAlD
Hydroxocobalamin—MUT—midbrain—malignant glioma	0.00569	0.024	CbGeAlD
Hydroxocobalamin—MTRR—medulla oblongata—malignant glioma	0.00559	0.0236	CbGeAlD
Hydroxocobalamin—MUT—spinal cord—malignant glioma	0.00555	0.0234	CbGeAlD
Hydroxocobalamin—Thrombosis—Carmustine—malignant glioma	0.00553	0.0434	CcSEcCtD
Hydroxocobalamin—Lung disorder—Temozolomide—malignant glioma	0.00534	0.0419	CcSEcCtD
Hydroxocobalamin—MMAA—brain—malignant glioma	0.00532	0.0224	CbGeAlD
Hydroxocobalamin—MTRR—midbrain—malignant glioma	0.00511	0.0215	CbGeAlD
Hydroxocobalamin—MTRR—spinal cord—malignant glioma	0.00499	0.021	CbGeAlD
Hydroxocobalamin—MMAB—brain—malignant glioma	0.00499	0.021	CbGeAlD
Hydroxocobalamin—MTR—medulla oblongata—malignant glioma	0.00488	0.0205	CbGeAlD
Hydroxocobalamin—Memory impairment—Temozolomide—malignant glioma	0.00482	0.0378	CcSEcCtD
Hydroxocobalamin—CASP9—brain—malignant glioma	0.00466	0.0196	CbGeAlD
Hydroxocobalamin—TCN2—brain—malignant glioma	0.00455	0.0191	CbGeAlD
Hydroxocobalamin—MUT—central nervous system—malignant glioma	0.0045	0.019	CbGeAlD
Hydroxocobalamin—Extravasation—Carmustine—malignant glioma	0.00448	0.0352	CcSEcCtD
Hydroxocobalamin—MTR—midbrain—malignant glioma	0.00446	0.0188	CbGeAlD
Hydroxocobalamin—MUT—cerebellum—malignant glioma	0.0044	0.0185	CbGeAlD
Hydroxocobalamin—MTR—spinal cord—malignant glioma	0.00435	0.0183	CbGeAlD
Hydroxocobalamin—MTRR—central nervous system—malignant glioma	0.00405	0.017	CbGeAlD
Hydroxocobalamin—MTRR—cerebellum—malignant glioma	0.00396	0.0167	CbGeAlD
Hydroxocobalamin—Injection site reaction—Carmustine—malignant glioma	0.00389	0.0305	CcSEcCtD
Hydroxocobalamin—MUT—brain—malignant glioma	0.00358	0.0151	CbGeAlD
Hydroxocobalamin—MTR—central nervous system—malignant glioma	0.00353	0.0149	CbGeAlD
Hydroxocobalamin—MTR—cerebellum—malignant glioma	0.00345	0.0145	CbGeAlD
Hydroxocobalamin—Phlebitis—Carmustine—malignant glioma	0.0033	0.0259	CcSEcCtD
Hydroxocobalamin—Swelling—Carmustine—malignant glioma	0.00322	0.0253	CcSEcCtD
Hydroxocobalamin—MTRR—brain—malignant glioma	0.00321	0.0135	CbGeAlD
Hydroxocobalamin—Hot flush—Temozolomide—malignant glioma	0.00293	0.023	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Temozolomide—malignant glioma	0.00291	0.0228	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Carmustine—malignant glioma	0.00285	0.0224	CcSEcCtD
Hydroxocobalamin—MTR—brain—malignant glioma	0.0028	0.0118	CbGeAlD
Hydroxocobalamin—Hypokalaemia—Carmustine—malignant glioma	0.00258	0.0203	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Temozolomide—malignant glioma	0.0025	0.0196	CcSEcCtD
Hydroxocobalamin—Dysphagia—Carmustine—malignant glioma	0.00245	0.0193	CcSEcCtD
Hydroxocobalamin—Dysphagia—Temozolomide—malignant glioma	0.00237	0.0186	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Carmustine—malignant glioma	0.00194	0.0152	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Temozolomide—malignant glioma	0.00187	0.0147	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Temozolomide—malignant glioma	0.00187	0.0147	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Temozolomide—malignant glioma	0.00186	0.0146	CcSEcCtD
Hydroxocobalamin—Eye disorder—Carmustine—malignant glioma	0.00184	0.0144	CcSEcCtD
Hydroxocobalamin—Eye disorder—Temozolomide—malignant glioma	0.00177	0.0139	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Temozolomide—malignant glioma	0.00176	0.0138	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Carmustine—malignant glioma	0.00175	0.0138	CcSEcCtD
Hydroxocobalamin—Angiopathy—Temozolomide—malignant glioma	0.00172	0.0135	CcSEcCtD
Hydroxocobalamin—Mental disorder—Carmustine—malignant glioma	0.00172	0.0135	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Temozolomide—malignant glioma	0.00171	0.0135	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Temozolomide—malignant glioma	0.00171	0.0134	CcSEcCtD
Hydroxocobalamin—Erythema—Carmustine—malignant glioma	0.00171	0.0134	CcSEcCtD
Hydroxocobalamin—Chills—Temozolomide—malignant glioma	0.0017	0.0134	CcSEcCtD
Hydroxocobalamin—Mental disorder—Temozolomide—malignant glioma	0.00166	0.0131	CcSEcCtD
Hydroxocobalamin—Erythema—Temozolomide—malignant glioma	0.00165	0.013	CcSEcCtD
Hydroxocobalamin—Agitation—Carmustine—malignant glioma	0.00157	0.0123	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Temozolomide—malignant glioma	0.00153	0.012	CcSEcCtD
Hydroxocobalamin—Agitation—Temozolomide—malignant glioma	0.00152	0.0119	CcSEcCtD
Hydroxocobalamin—Angioedema—Temozolomide—malignant glioma	0.00151	0.0118	CcSEcCtD
Hydroxocobalamin—Malaise—Temozolomide—malignant glioma	0.00149	0.0117	CcSEcCtD
Hydroxocobalamin—Chest pain—Carmustine—malignant glioma	0.00146	0.0114	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0014	0.011	CcSEcCtD
Hydroxocobalamin—Oedema—Carmustine—malignant glioma	0.0014	0.011	CcSEcCtD
Hydroxocobalamin—Discomfort—Temozolomide—malignant glioma	0.00139	0.0109	CcSEcCtD
Hydroxocobalamin—Infection—Carmustine—malignant glioma	0.00139	0.0109	CcSEcCtD
Hydroxocobalamin—Tachycardia—Carmustine—malignant glioma	0.00136	0.0107	CcSEcCtD
Hydroxocobalamin—Oedema—Temozolomide—malignant glioma	0.00135	0.0106	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Temozolomide—malignant glioma	0.00135	0.0106	CcSEcCtD
Hydroxocobalamin—Infection—Temozolomide—malignant glioma	0.00134	0.0105	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Temozolomide—malignant glioma	0.00132	0.0104	CcSEcCtD
Hydroxocobalamin—Skin disorder—Temozolomide—malignant glioma	0.00131	0.0103	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Carmustine—malignant glioma	0.00124	0.00976	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Carmustine—malignant glioma	0.0012	0.00945	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Temozolomide—malignant glioma	0.0012	0.00944	CcSEcCtD
Hydroxocobalamin—Pain—Carmustine—malignant glioma	0.00119	0.00937	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Temozolomide—malignant glioma	0.00119	0.00932	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00116	0.00914	CcSEcCtD
Hydroxocobalamin—Pain—Temozolomide—malignant glioma	0.00115	0.00905	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Carmustine—malignant glioma	0.00115	0.00902	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Temozolomide—malignant glioma	0.00111	0.00872	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carmustine—malignant glioma	0.0011	0.00866	CcSEcCtD
Hydroxocobalamin—Urticaria—Temozolomide—malignant glioma	0.00107	0.00841	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Temozolomide—malignant glioma	0.00107	0.00837	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Carmustine—malignant glioma	0.00103	0.00807	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Temozolomide—malignant glioma	0.000994	0.0078	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Carmustine—malignant glioma	0.000955	0.00749	CcSEcCtD
Hydroxocobalamin—Pruritus—Temozolomide—malignant glioma	0.000954	0.00749	CcSEcCtD
Hydroxocobalamin—Dizziness—Carmustine—malignant glioma	0.000923	0.00724	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Temozolomide—malignant glioma	0.000923	0.00724	CcSEcCtD
Hydroxocobalamin—Dizziness—Temozolomide—malignant glioma	0.000892	0.007	CcSEcCtD
Hydroxocobalamin—Rash—Carmustine—malignant glioma	0.00088	0.00691	CcSEcCtD
Hydroxocobalamin—Dermatitis—Carmustine—malignant glioma	0.000879	0.0069	CcSEcCtD
Hydroxocobalamin—Headache—Carmustine—malignant glioma	0.000874	0.00686	CcSEcCtD
Hydroxocobalamin—Rash—Temozolomide—malignant glioma	0.00085	0.00667	CcSEcCtD
Hydroxocobalamin—Dermatitis—Temozolomide—malignant glioma	0.00085	0.00667	CcSEcCtD
Hydroxocobalamin—Headache—Temozolomide—malignant glioma	0.000845	0.00663	CcSEcCtD
Hydroxocobalamin—Nausea—Carmustine—malignant glioma	0.000829	0.00651	CcSEcCtD
Hydroxocobalamin—Nausea—Temozolomide—malignant glioma	0.000801	0.00629	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—malignant glioma	9.65e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—malignant glioma	9.58e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—malignant glioma	9.58e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CD—malignant glioma	9.58e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CB—malignant glioma	9.53e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—malignant glioma	9.52e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN2B—malignant glioma	9.49e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MDM2—malignant glioma	9.4e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—malignant glioma	9.38e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RAF1—malignant glioma	9.37e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PDGFRA—malignant glioma	9.34e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—malignant glioma	9.3e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—malignant glioma	9.29e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-B—malignant glioma	9.28e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—malignant glioma	9.27e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—malignant glioma	9.25e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—malignant glioma	9.25e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CB—malignant glioma	9.23e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—H3F3A—malignant glioma	9.19e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGF2—malignant glioma	9.17e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BAD—malignant glioma	9.17e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CB—malignant glioma	9.15e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—malignant glioma	9.14e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CG—malignant glioma	9.12e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—malignant glioma	9.1e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCR3—malignant glioma	9.1e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOTCH1—malignant glioma	9.08e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HES1—malignant glioma	9.06e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NCOR1—malignant glioma	9e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—malignant glioma	8.92e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—malignant glioma	8.92e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD80—malignant glioma	8.9e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APC—malignant glioma	8.88e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTRK2—malignant glioma	8.85e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—YWHAE—malignant glioma	8.85e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FLT1—malignant glioma	8.81e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—malignant glioma	8.81e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—malignant glioma	8.78e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGF—malignant glioma	8.78e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—DUSP6—malignant glioma	8.77e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTPN11—malignant glioma	8.73e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAG1—malignant glioma	8.66e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH3—malignant glioma	8.62e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PDGFRA—malignant glioma	8.62e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—malignant glioma	8.6e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-A—malignant glioma	8.6e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MDM2—malignant glioma	8.58e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RAF1—malignant glioma	8.55e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CB—malignant glioma	8.51e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—malignant glioma	8.51e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—malignant glioma	8.49e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—malignant glioma	8.49e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FBXW7—malignant glioma	8.48e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—malignant glioma	8.46e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—malignant glioma	8.44e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PDGFB—malignant glioma	8.39e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—malignant glioma	8.36e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—malignant glioma	8.36e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CB—malignant glioma	8.35e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—malignant glioma	8.35e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGFR1—malignant glioma	8.35e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BDKRB2—malignant glioma	8.32e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—malignant glioma	8.32e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—malignant glioma	8.29e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—malignant glioma	8.29e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—malignant glioma	8.27e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—malignant glioma	8.23e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAV1—malignant glioma	8.17e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT2—malignant glioma	8.13e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—malignant glioma	8.11e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—malignant glioma	8.11e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CD—malignant glioma	8.02e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—malignant glioma	7.97e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HLA-A—malignant glioma	7.94e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—malignant glioma	7.94e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—malignant glioma	7.91e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—malignant glioma	7.91e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—malignant glioma	7.9e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—malignant glioma	7.86e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—malignant glioma	7.81e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—malignant glioma	7.78e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PDGFB—malignant glioma	7.75e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—malignant glioma	7.74e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH2—malignant glioma	7.74e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR1—malignant glioma	7.71e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—malignant glioma	7.66e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—malignant glioma	7.66e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—malignant glioma	7.59e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—malignant glioma	7.59e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KNG1—malignant glioma	7.57e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BAD—malignant glioma	7.48e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGF2—malignant glioma	7.48e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—malignant glioma	7.44e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—malignant glioma	7.36e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CAV1—malignant glioma	7.34e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—malignant glioma	7.31e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—malignant glioma	7.3e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD80—malignant glioma	7.26e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NTRK1—malignant glioma	7.21e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—malignant glioma	7.21e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—malignant glioma	7.18e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGF—malignant glioma	7.16e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—malignant glioma	7.14e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTPN11—malignant glioma	7.12e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—malignant glioma	7.11e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—malignant glioma	7.11e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—malignant glioma	7.04e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—malignant glioma	7.04e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—malignant glioma	6.99e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—malignant glioma	6.99e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAF1—malignant glioma	6.97e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—malignant glioma	6.94e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—malignant glioma	6.94e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—malignant glioma	6.93e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BAD—malignant glioma	6.9e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—malignant glioma	6.9e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—malignant glioma	6.84e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—malignant glioma	6.81e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—malignant glioma	6.75e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—malignant glioma	6.74e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—malignant glioma	6.72e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP3—malignant glioma	6.71e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD80—malignant glioma	6.7e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—malignant glioma	6.69e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—malignant glioma	6.69e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—malignant glioma	6.65e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT2—malignant glioma	6.63e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—malignant glioma	6.61e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGF—malignant glioma	6.61e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTPN11—malignant glioma	6.57e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—malignant glioma	6.54e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTK2—malignant glioma	6.46e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—malignant glioma	6.45e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—malignant glioma	6.45e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—malignant glioma	6.43e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—malignant glioma	6.37e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—malignant glioma	6.35e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—malignant glioma	6.34e-05	9.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—malignant glioma	6.32e-05	9.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCOR1—malignant glioma	6.31e-05	9.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—malignant glioma	6.28e-05	9.9e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—malignant glioma	6.2e-05	9.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT2—malignant glioma	6.12e-05	9.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF2—malignant glioma	6.1e-05	9.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—malignant glioma	6.07e-05	9.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—malignant glioma	6.04e-05	9.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRA—malignant glioma	6.04e-05	9.51e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—malignant glioma	5.99e-05	9.44e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—malignant glioma	5.89e-05	9.28e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—malignant glioma	5.89e-05	9.28e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—malignant glioma	5.88e-05	9.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—malignant glioma	5.88e-05	9.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—malignant glioma	5.86e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SPP1—malignant glioma	5.86e-05	9.23e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—malignant glioma	5.81e-05	9.15e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—malignant glioma	5.81e-05	9.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—malignant glioma	5.81e-05	9.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—malignant glioma	5.79e-05	9.11e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—malignant glioma	5.75e-05	9.05e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—malignant glioma	5.75e-05	9.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—malignant glioma	5.74e-05	9.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—malignant glioma	5.7e-05	8.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—malignant glioma	5.7e-05	8.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAF1—malignant glioma	5.68e-05	8.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—malignant glioma	5.65e-05	8.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF2—malignant glioma	5.63e-05	8.86e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—malignant glioma	5.62e-05	8.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—malignant glioma	5.62e-05	8.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—malignant glioma	5.58e-05	8.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—malignant glioma	5.56e-05	8.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—malignant glioma	5.55e-05	8.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—malignant glioma	5.54e-05	8.72e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—malignant glioma	5.49e-05	8.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFB—malignant glioma	5.42e-05	8.54e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—malignant glioma	5.4e-05	8.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR1—malignant glioma	5.4e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—malignant glioma	5.31e-05	8.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—malignant glioma	5.27e-05	8.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—malignant glioma	5.26e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAF1—malignant glioma	5.25e-05	8.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—malignant glioma	5.19e-05	8.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—malignant glioma	5.19e-05	8.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CAV1—malignant glioma	5.14e-05	8.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—malignant glioma	5.12e-05	8.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—malignant glioma	5.12e-05	8.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—malignant glioma	5.1e-05	8.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—malignant glioma	5.09e-05	8.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—malignant glioma	5.08e-05	8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—malignant glioma	5.08e-05	7.99e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—malignant glioma	5.06e-05	7.97e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—malignant glioma	4.92e-05	7.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—F2—malignant glioma	4.89e-05	7.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FN1—malignant glioma	4.89e-05	7.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—malignant glioma	4.89e-05	7.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BAD—malignant glioma	4.83e-05	7.61e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—malignant glioma	4.82e-05	7.58e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—malignant glioma	4.82e-05	7.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—malignant glioma	4.8e-05	7.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—malignant glioma	4.79e-05	7.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—malignant glioma	4.78e-05	7.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—malignant glioma	4.74e-05	7.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD80—malignant glioma	4.69e-05	7.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—malignant glioma	4.68e-05	7.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—malignant glioma	4.68e-05	7.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGF—malignant glioma	4.63e-05	7.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTPN11—malignant glioma	4.6e-05	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—malignant glioma	4.59e-05	7.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—malignant glioma	4.56e-05	7.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—malignant glioma	4.52e-05	7.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—malignant glioma	4.43e-05	6.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—malignant glioma	4.4e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—malignant glioma	4.29e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT2—malignant glioma	4.28e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—malignant glioma	4.26e-05	6.71e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—malignant glioma	4.24e-05	6.68e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—malignant glioma	4.16e-05	6.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—malignant glioma	4.15e-05	6.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—malignant glioma	4.12e-05	6.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—malignant glioma	3.96e-05	6.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF2—malignant glioma	3.94e-05	6.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—malignant glioma	3.9e-05	6.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—malignant glioma	3.69e-05	5.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—malignant glioma	3.68e-05	5.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—malignant glioma	3.68e-05	5.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAF1—malignant glioma	3.67e-05	5.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—malignant glioma	3.64e-05	5.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—malignant glioma	3.6e-05	5.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—malignant glioma	3.59e-05	5.65e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—malignant glioma	3.48e-05	5.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—malignant glioma	3.47e-05	5.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—malignant glioma	3.45e-05	5.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—malignant glioma	3.4e-05	5.35e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—malignant glioma	3.39e-05	5.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—malignant glioma	3.38e-05	5.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—malignant glioma	3.3e-05	5.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—malignant glioma	3.29e-05	5.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—malignant glioma	3.12e-05	4.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—malignant glioma	3.12e-05	4.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—malignant glioma	3.1e-05	4.88e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—malignant glioma	2.84e-05	4.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—malignant glioma	2.8e-05	4.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—malignant glioma	2.77e-05	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—malignant glioma	2.76e-05	4.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—malignant glioma	2.58e-05	4.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—malignant glioma	2.55e-05	4.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—malignant glioma	2.52e-05	3.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—malignant glioma	2.38e-05	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—malignant glioma	2.19e-05	3.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—malignant glioma	2.12e-05	3.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—malignant glioma	1.79e-05	2.81e-05	CbGpPWpGaD
